by John Conrad | Mar 31, 2021 | Wednesday1
Rhaeos has developed FlowSense, a noninvasive wearable platform technology initially targeting hydrocephalus, a life threatening neurological condition characterized by excess fluid on the brain, that affects over 1M Americans today. This $2B/yr problem is treated...
